ORAL MEDICINE| Volume 130, ISSUE 4, e290-e293, October 2020

Sclerotherapy for atypical oral manifestation of Cowden syndrome

      Cowden syndrome is an autosomal dominant disorder characterized by hamartomas, as well as benign and malignant neoplasms that may present in organ systems throughout the body. It also poses an increased lifetime cancer risk in those with the disorder. Its clinical presentation is often variable, and diagnosis can be challenging. In the head and neck region, it can present as thyroid enlargement or mass formation, cutaneous and mucocutaneous lesions of the skin and the oral cavity. The most typical oral manifestations of Cowden syndrome are oral papillomatosis and a cobblestone appearance of the mucosa. We present a case of vascular malformation of the tongue in a patient with Cowden syndrome. This lesion was similar in appearance to a cutaneous hamartoma on the patient's upper extremity. He had received prior surgical intervention for this tongue mass, and complete resection was recommended subsequently. However, in search of a less invasive treatment to minimize impact on speech and oral function, sclerotherapy was performed, resulting in resolution of the lesion. Sclerotherapy is a well-documented treatment for head and neck vascular malformations, but it is not universally employed. In our patient with atypical oral manifestation of Cowden syndrome, bleomycin sclerotherapy was employed, resulting in resolution of the lesion, as well as preservation of speech articulation and oral function.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


        • Porto ACS
        • Roider E
        • Ruzicka T
        Cowden syndrome: report of a case and brief review of literature.
        Ann Bras Dermatol. 2013; 88: 52-55
        • Reddy KK
        • Anusha A
        • Maloth K
        • Sunitha K
        • Thakur M
        Mucocutaneous manifestations of Cowden's syndrome.
        Indian Dermatol Online J. 2016; 7: 512
        • Hammami S
        • Berriche O
        • Ali HB
        • Hellara O
        • Ansar F
        • Mahjoub S
        Managing the risk of cancer in Cowden syndrome: a case report.
        J Med Case Rep. 2012; 6: 225
        • Upadhyaya P
        • OMS Torres A
        • Agarwal R
        Cowden syndrome: a dural arterial venous malformation.
        Neurology. 2017; 73: 3
        • Fernandes D-T
        • Elias R-A
        • Santos-Silva A-R
        • Vargas P-A
        • Lopes M-A
        Benign oral vascular lesions treated by sclerotherapy with ethanolamine oleate: a retrospective study of 43 patients.
        Med Oral Patol Oral Cir Bucal. 2018; 23: e180-e187
        • Melbarde-Gorkusa I
        • Irmejs A
        • Berzina D
        • et al.
        Challenges in the management of a patient with Cowden syndrome: case report and literature review.
        Hered Cancer Clin Pract. 2012; 10: 5
        • Gustafson S
        • Zbuk KM
        • Scacheri C
        • Eng C
        Cowden syndrome.
        Semin Oncol. 2007; 34: 428-434
        • Vlahovic A
        • Gazikalovic A
        • Adjic O
        Bleomycin sclerotherapy for lymphatic malformation after unsuccessful surgical excision: case report.
        Acta Otorhinolaryngol Ital. 2015; 35: 365-367
        • Tolentino E
        • de S
        • Centurion BS
        • Ferreira LHC
        • de Souza AP
        • Damante JH
        • Rubira-Bullen IRF
        Oral adverse effects of head and neck radiotherapy: literature review and suggestion of a clinical oral care guideline for irradiated patients.
        J Appl Oral Sci. 2011; 19: 448-454
        • Mathur NN
        • Rana I
        • Bothra R
        • Dhawan R
        • Kathuria G
        • Pradhan T
        Bleomycin sclerotherapy in congenital lymphatic and vascular malformations of head and neck.
        Int J Pediatr Otorhinolaryngol. 2005; 69: 75-80
        • Karavelioglu A
        • Temucin CM
        • Tanyel FC
        • Ciftci AO
        • Senocak ME
        • Karnak I
        Sclerotherapy with bleomycin does not adversely affect facial nerve function in children with cervicofacial cystic lymphatic malformation.
        J Pediatr Surg. 2010; 45: 1627-1632
        • Muir T
        • Kirsten M
        • Fourie P
        • Dippenaar N
        • Ionescu GO
        Intralesional bleomycin injection (IBI) treatment for haemangiomas and congenital vascular malformations.
        Pediatr Surg Int. 2004; 19: 766-773
        • Sainsbury DCG
        • Kessell G
        • Fall AJ
        • Hampton FJ
        • Guhan A
        • Muir T
        Intralesional bleomycin injection treatment for vascular birthmarks: a 5-year experience at a single United Kingdom unit.
        Plast Reconstr Surg. 2011; 127: 2031-2044